| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/19/2013 | US8377420 Injectable void filler for soft tissue augmentation |
| 02/19/2013 | CA2575473C Radicals and their use as paramagnetic agents in a dnp process |
| 02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 02/14/2013 | WO2013021300A2 Imaging using sets of carbon nanotubes |
| 02/14/2013 | WO2013020951A1 Polynucleotide, polypeptide, animal model and method for the development of complement system modulators |
| 02/14/2013 | WO2012173003A3 Medical tissue-marker and manufacturing method for same |
| 02/14/2013 | WO2012074840A3 Compositions and methods for in vivo imaging |
| 02/14/2013 | US20130039861 Dye Conjugated Peptides for Fluorescent Imaging |
| 02/14/2013 | US20130039860 Fluorescent imaging with substituted cyanine dyes |
| 02/14/2013 | US20130039859 Passivated nanoparticles |
| 02/14/2013 | US20130039858 Nir materials and nanomaterials for theranostic applications |
| 02/14/2013 | US20130039857 Methods of suppressing cancer, increasing weight loss and/or increasing insulin sensitivity |
| 02/14/2013 | US20130039856 Products and Methods |
| 02/14/2013 | US20130039855 Aptamer to fgf2 and use thereof |
| 02/14/2013 | US20130039854 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
| 02/14/2013 | US20130039853 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/14/2013 | US20130039852 Methods of targeting cells for diagnosis and therapy |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | US20130039847 Liposomes for pulmonary administration |
| 02/14/2013 | US20130038330 Systems, Devices, Methods, and Compositions Including Ferromagnetic Structures |
| 02/13/2013 | EP2555803A1 Process for preparing hyperpolarized substrates and method for mri |
| 02/13/2013 | CN1893982B Menthol-containing preparation |
| 02/13/2013 | CN102925427A Acrylyl lysine translation system and application thereof |
| 02/13/2013 | CN102923782A Preparation method and biological application of T1-T1 synergistic effect gadolinium chelate manganous-manganic oxide nano particle |
| 02/13/2013 | CN102921022A Drug-loaded nanoparticle with nuclide imaging, fluorescence imaging and MRI functions, and preparation method and application thereof |
| 02/13/2013 | CN102600484B Application of shikonin serving as endoscope staining agent, and endoscope staining composition |
| 02/13/2013 | CN102065905B Methods for radiolabelling synthetic polymers |
| 02/13/2013 | CN102001985B Fullerene multi-nitrogen heterocyclic water-soluble derivatives as well as preparation method and application thereof |
| 02/13/2013 | CN101948921B Application of NOB1 gene in treating brain glioma disease |
| 02/12/2013 | US8374965 System and method for verifying the contents of a filled, capped pharmaceutical prescription |
| 02/12/2013 | US8372798 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability |
| 02/12/2013 | US8372654 Method for investigating the fate of a test compound or the stateof a biological system by means of NMR of hyperpolarised NMR active nuclei |
| 02/12/2013 | CA2545362C Assembly of gas-filled microvesicle with active component for contrast imaging |
| 02/12/2013 | CA2518082C Methods for diagnosing skin lesions |
| 02/12/2013 | CA2498936C Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 02/12/2013 | CA2487908C Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 02/07/2013 | WO2013020040A2 Radiated cancer cells as a vehicle for cancer nanotherapy |
| 02/07/2013 | WO2013019917A2 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality |
| 02/07/2013 | WO2013019681A2 Selective delivery molecules and methods of use |
| 02/07/2013 | WO2013019137A1 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
| 02/07/2013 | WO2013018094A1 Device, system and method for in-vivo immunoassay |
| 02/07/2013 | WO2012174049A3 Compositions and methods for controlling neuronal excitation |
| 02/07/2013 | WO2012138379A3 Multifunctional chelator-free radioactive nanoparticles for imaging and therapy |
| 02/07/2013 | US20130036481 Use of perlecan domain v in treating amyloidogenic disease |
| 02/07/2013 | US20130035566 Method and Apparatus for Enhancement of Transdermal Transport |
| 02/07/2013 | US20130034502 Color Changing Cosmetic |
| 02/07/2013 | US20130034501 Diarylhydantoin compounds |
| 02/07/2013 | US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use |
| 02/07/2013 | US20130034499 Sgii as a prognostic marker in conditions which require critical care |
| 02/07/2013 | US20130034498 Optical microlabels: shapes and reflectors |
| 02/07/2013 | CA2841249A1 Selective delivery molecules and methods of use |
| 02/06/2013 | EP2552825A2 Nir materials and nanomaterials for theranostic applications |
| 02/06/2013 | EP2552493A1 Hydroxylated phosphorylated contrast enhancement agents |
| 02/06/2013 | EP2552492A2 Single isomeric conjugates of rhodamine dyes |
| 02/06/2013 | EP2552491A1 Staining composition |
| 02/06/2013 | CN102917701A Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 02/06/2013 | CN102917699A Dendrimer compositions and methods of synthesis |
| 02/06/2013 | CN102911373A Preparation method of HPEI (hyperbranched polyethyleneimine)-encapsulated iron oxide magnetic nano particles |
| 02/06/2013 | CN102911194A Preparation method of nano rare earth carboxylic acid coordination polymer and application thereof |
| 02/06/2013 | CN102908634A Double-strand quaternary ammonium type nuclear magnetic resonance imaging contrast agent and preparation method thereof |
| 02/06/2013 | CN102908633A Multifunctional gold and silver core-shell nanoparticles and preparation method |
| 02/06/2013 | CN102908632A Process for producing placebo of traditional Chinese medicine formula granule |
| 02/06/2013 | CN102908205A Preparation method of permanent middle cerebral artery occlusion model |
| 02/06/2013 | CN102907357A Building method and application of zebra fish hyperlipidemia model |
| 02/06/2013 | CN102294038B Method for preparing computed tomography (CT)/magnatic resonance imaging (MRI) bimodal imaging contrast agent based on dendrimers |
| 02/06/2013 | CN101631818B Polylysine dendrimer contrast agent imaging macromolecule |
| 02/06/2013 | CN101166547B MRI contrast agents comprising CEST active paramagnetic complexes |
| 02/05/2013 | US8367738 Smooth muscle contraction inhibitors |
| 02/05/2013 | US8367075 Synergistic combination and method thereof |
| 02/05/2013 | US8367041 Radiographic contrast agent for postmortem, experimental and diagnostic angiography |
| 02/05/2013 | US8367040 Contrast agents and methods for preparing contrast agents |
| 02/05/2013 | US8367039 Compounds for the diagnosis of diseases associated with VCAM expression |
| 02/05/2013 | US8367038 Therameutin modulators |
| 02/05/2013 | CA2474142C Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 01/31/2013 | WO2012135562A3 Polymer conjugates targeting cells and methods related thereto |
| 01/31/2013 | US20130031646 Model system of acanthamoeba keratitis syndrome and method for selecting a treatment thereof |
| 01/31/2013 | US20130030282 Synthesis and characterization of near ir fluorescent magnetic and non-magnetic albumin nanoparticles for biomedical applications |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | US20130028842 Method of treating binge eating disorder |
| 01/31/2013 | US20130028841 Mixing device, mixing tube, drug solution injecting system, and drug solution mixing method |
| 01/31/2013 | US20130028840 Fabrication of conducting open nanoshells |
| 01/31/2013 | US20130028839 Polymer coated sers nanotag |
| 01/31/2013 | US20130028837 Contrast agents for myocardial perfusion imaging |
| 01/31/2013 | US20130028836 Chlorotoxin polypeptides and conjugates and uses thereof |
| 01/30/2013 | EP2550022A1 Preparation of stabilised x-ray diagnostic composition |
| 01/30/2013 | EP2549999A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 01/30/2013 | EP2549925A1 Multimodal diagnostic technology for early stage cancer lesions |
| 01/30/2013 | CN102905696A Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same |
| 01/30/2013 | CN102898461A Method for preparing fluorescent and magnetic resonance dual-functional nanometer super-paramagnetic particles for detecting life system |
| 01/30/2013 | CN102895680A Theranostic agent and preparation method thereof |
| 01/30/2013 | CN102895679A Shell structure nano material and preparation method thereof |
| 01/30/2013 | CN102895678A Liver-targeted magnetic resonance imaging contrast agent based on oleanolic acid and preparation method thereof |
| 01/30/2013 | CN102895664A Gadolinium stabilizing amorphous calcium carbonate nanocomposite material and preparation method |
| 01/30/2013 | CN102406951B Thiol-polyethylene glycol modified magneto-optical composite nano-material and its application |
| 01/30/2013 | CN102218150B Novel liver-targeting nanometer Fe3O4MRI (Magnetic Resonance Imaging) contrast medium and preparation method |
| 01/30/2013 | CN102114249B Oxygen carrying coronary contrast medium and preparation method thereof |
| 01/30/2013 | CN101721709B Calcium phosphate and amphiphilic polymer composite medicament-carrying nano-microsphere, preparation method and application |
| 01/29/2013 | US8361775 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 01/29/2013 | US8361494 Biomimetic iron-oxide-containing lipoprotein and related materials |
| 01/29/2013 | US8361454 PVA particle for temporary embolic material and production process thereof, and temporary embolic material |